Press Releases

WASHINGTON, Sept. 14 – Sen. Bernie Sanders (I-Vt.) issued the following statement Wednesday after Monsanto agreed to a buyout offer from Bayer in a deal that would create the world’s largest supplier of seeds and farm chemicals: “The attempted takeover of Monsanto by Bayer is a threat to all Americans. These mergers boost the profits of huge corporations and leave

WASHINGTON, Sept. 14 – Sen. Bernie Sanders (I-Vt.) and other leading congressional critics of a proposed Pacific Rim trade deal held a Capitol Hill news conference Tuesday as a coalition of labor, environmental and religious groups launched a “day of action” to urge Congress to block a vote on the job-killing trade pact. The coalition of multi-national corporations, lobbyists and

WASHINGTON, Sept. 13 – During a rally outside the White House Tuesday with leaders of the Standing Rock Sioux tribe and other tribal nations, Sen. Bernie Sanders (I-Vt.) called on President Barack Obama to block construction of the Dakota Access oil pipeline. “If there is one profound lesson that the Native American people have taught us, it is that all

WASHINGTON, Sept. 13 – Sen. Bernie Sanders issued the following statement Tuesday on a new Census Bureau report on income, poverty, pay equity and health insurance: “When President Obama took office almost eight years ago, we were losing 800,000 jobs a month and median family income was plummeting during the worst economic downturn since the Great Depression. Today, we are

WASHINGTON, Sept. 8 – In a letter sent to Aetna’s CEO today, Sens. Bernie Sanders (I-Vt.), Elizabeth Warren (D-Mass.), Edward J. Markey (D-Mass.), Sherrod Brown (D-Ohio) and Bill Nelson (D-Fla.) raised questions about the company’s decision to withdraw from the federal Affordable Care Act (ACA) health care exchanges after the Department of Justice (DOJ) challenged Aetna’s proposed merger with Humana. “Aetna’s

WASHINGTON, Aug. 30 — In a letter sent today to the CEO of pharmaceutical company Mylan, Sen. Bernie Sanders (I-Vt.) and 19 Democratic senators expressed their serious concerns about the company’s recent price hikes for the life-saving EpiPen Auto-Injector. The senators raised questions about Mylan’s decision to expand its patient assistance program, which allows the company to sharply increase prices while